Nasopharyngeal Cancer Clinical Trials in Guangzhou, Guangdong
5 recruitingGuangzhou, Guangdong, China
Showing 1–5 of 5 trials
Recruiting
Phase 3
QL1706 (PD-1/CTLA-4 Bi-specific Antibody) and Chemoradiotherapy in Locoregionally-advanced Nasopharyngeal Carcinoma.
Nasopharyngeal CancerNasopharyngeal Cancinoma (NPC)
Sun Yat-Sen University Cancer Center580 enrolled19 locationsNCT06749899
Recruiting
Phase 2
Adebrelimab and Chemoradiotherapy in High-risk LANPC
Nasopharyngeal CancerNasopharyngeal Carcinoma
Sun Yat-sen University50 enrolled4 locationsNCT06349889
Recruiting
A Multicentre Study on Features of the Gut Microbiota of Patients With Critical Chronic Diseases in China
Liver CancerPancreatic CancerGastric Cancer+8 more
Zhujiang Hospital12,000 enrolled50 locationsNCT05638269
Recruiting
Not Applicable
Endoscopic Nasopharyngectomy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma Patients
Endoscopic SurgeryNasopharyngeal CarcinomaPrimary Napharyngeal Carcinama+1 more
Sun Yat-sen University228 enrolled5 locationsNCT03353467
Recruiting
Phase 3
Concurrent and Adjuvant PD1 Treatment Combined With Chemo-radiotherapy for High-risk Nasopharyngeal Carcinoma
ChemotherapyRadiotherapyNasopharyngeal Cancer+1 more
Sun Yat-sen University388 enrolled6 locationsNCT04453826